Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin

被引:21
|
作者
Delort, Laetitia [1 ]
Bougaret, Lauriane [1 ]
Cholet, Juliette [1 ]
Vermerie, Marion [1 ]
Billard, Hermine [1 ]
Decombat, Caroline [1 ]
Bourgne, Celine [2 ]
Berger, Marc [2 ]
Dumontet, Charles [3 ]
Caldefie-Chezet, Florence [1 ]
机构
[1] Univ Clermont Auvergne, CRNH Auvergne, INRA, UNH, F-63000 Clermont Ferrand, France
[2] CHU Estaing, Serv Hematol Biol, F-63000 Clermont Ferrand, France
[3] Univ Lyon 1, INSERM U1052, CNRS 5286, Canc Res Ctr Lyon, F-69008 Lyon, France
关键词
breast cancer; adipose secretome; leptin; hormonal therapy resistance; cancer stem cells; ADIPOSE-TISSUE; ENDOCRINE THERAPY; STEM-CELLS; IDENTIFICATION; INTERLEUKIN-6; OBESITY; STAT3;
D O I
10.3390/nu11122839
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Obesity, a recognized risk factor for breast cancer in postmenopausal women, is associated with higher mortality rates regardless of menopausal status, which could in part be explained by therapeutic escape. Indeed, adipose microenvironment has been described to influence the efficiency of chemo- and hormonal therapies. Residual cancer stem cells could also have a key role in this process. To understand the mechanisms involved in the reduced efficacy of hormonal therapy on breast cancer cells in the presence of adipose secretome, human adipose stem cells (hMAD cell line) differentiated into mature adipocytes were co-cultured with mammary breast cancer cells and treated with hormonal therapies (tamoxifen, fulvestrant). Proliferation and apoptosis were measured (fluorescence test, impedancemetry, cytometry) and the gene expression profile was evaluated. Cancer stem cells were isolated from mammospheres made from MCF-7. The impact of chemo- and hormonal therapies and leptin was evaluated in this population. hMAD-differentiated mature adipocytes and their secretions were able to increase mammary cancer cell proliferation and to suppress the antiproliferative effect of tamoxifen, confirming previous data and validating our model. Apoptosis and cell cycle did not seem to be involved in this process. The evaluation of gene expression profiles suggested that STAT3 could be a possible target. On the contrary, leptin did not seem to be involved. The study of isolated cancer stem cells revealed that their proliferation was stimulated in the presence of anticancer therapies (tamoxifen, fulvestrant, doxorubicine) and leptin. Our study confirmed the role of adipocytes and their secretome, but above all, the role of communication between adipose and cancer cells in interfering with the efficiency of hormonal therapy. Among the pathophysiological mechanisms involved, leptin does not seem to interfere with the estrogenic pathway but seems to promote the proliferation of cancer stem cells.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Leptin-cytokine crosstalk in breast cancer
    Newman, Gale
    Gonzalez-Perez, Ruben Rene
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 382 (01) : 570 - 582
  • [2] Obesity and leptin in breast cancer angiogenesis
    Lagarde, Courtney B.
    Thapa, Kapil
    Cullen, Nicole M.
    Hawes, Mackenzie L.
    Salim, Khudeja
    Benz, Megan C.
    Dietrich, Sophie R.
    Burow, Brandon E.
    Bunnell, Bruce A.
    Martin, Elizabeth C.
    Collins-Burow, Bridgette M.
    Lynch, Ronald M.
    Hoang, Van T.
    Burow, Matthew E.
    Fang, Jennifer S.
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [3] Cancer-associated adipocytes: emerging supporters in breast cancer
    Zhao, Chongru
    Wu, Min
    Zeng, Ning
    Xiong, Mingchen
    Hu, Weijie
    Lv, Wenchang
    Yi, Yi
    Zhang, Qi
    Wu, Yiping
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [4] Cancer-Associated Adipocytes and Breast Cancer: Intertwining in the Tumor Microenvironment and Challenges for Cancer Therapy
    Wu, Chenghui
    Dong, Shuwen
    Huang, Renhong
    Chen, Xiaosong
    CANCERS, 2023, 15 (03)
  • [5] Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity
    Delort, Laetitia
    Rossary, Adrien
    Farges, Marie-Chantal
    Vasson, Marie-Paule
    Caldefie-Chezet, Florence
    LIFE SCIENCES, 2015, 140 : 37 - 48
  • [6] Molecular mechanisms of leptin and adiponectin in breast cancer
    Jarde, Thierry
    Perrier, Stephane
    Vasson, Marie-Paule
    Caldefie-Chezet, Florence
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (01) : 33 - 43
  • [7] Leptin and leptin receptor involvement in cancer development:: A study on human primary breast carcinoma
    Jarde, Thierry
    Caldefie-Chezet, Florence
    Damez, Mireille
    Mishellany, Florence
    Penault-Llorca, Frederique
    Guillot, Jean
    Vasson, Marie Paule
    ONCOLOGY REPORTS, 2008, 19 (04) : 905 - 911
  • [8] New approaches to reverse resistance to hormonal therapy in human breast cancer
    Weinberg, OK
    Marquez-Garban, DC
    Pietras, RJ
    DRUG RESISTANCE UPDATES, 2005, 8 (04) : 219 - 233
  • [9] Leptin and breast cancer: an overview
    Artac, Mehmet
    Altundag, Kadri
    MEDICAL ONCOLOGY, 2012, 29 (03) : 1510 - 1514
  • [10] Subcellular localization of leptin and leptin receptor in breast cancer detected in an electron microscopic study
    Al-Shibli, Saad M.
    Amjad, Nasser M.
    Al-Kubaisi, Muna K.
    Mizan, Shaikh
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 482 (04) : 1102 - 1106